Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Promixin for non-cystic fibrosis bronchiectasis with Pseudomonas aeruginosa infection
2008-005045-34Phase 3Completed
- Sponsor
- Profile Pharma
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis and Pseudomonal infection comparing Promixin with Vehicle control (2 arms). Primary endpoint: Time to pulmonary exacerbation. Started Oct 2008; status: completed.
02
Drugs
colistimethate sodium
03
Conditions
bronchiectasisPseudomonal infection
Beyond the preview
Go deeper on 2008-005045-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005045-34.